Literature DB >> 8739826

The pharmacokinetics of extended release felodipine in children.

D I Blowey, I Moncica, D Scolnik, G S Arbus, D Hébert, J W Balfe, G Koren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8739826     DOI： 10.1007/s002280050083

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

Review 1.  Pharmacologic treatment of chronic pediatric hypertension.

Authors:  Renee F Robinson; Milap C Nahata; Donald L Batisky; John D Mahan
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

2.  Clinical trial of extended-release felodipine in pediatric essential hypertension.

Authors:  Howard Trachtman; Rachel Frank; John D Mahan; Ronald Portman; Irene Restaino; Tej K Matoo; Conrad Tou; Michael Klibaner
Journal:  Pediatr Nephrol       Date:  2003-04-17       Impact factor: 3.714

Review 3.  A review of calcium channel antagonists in the treatment of pediatric hypertension.

Authors:  Shobha Sahney
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 4.  Clinical pharmacokinetics of vasodilators. Part I.

Authors:  R Kirsten; K Nelson; D Kirsten; B Heintz
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

5.  Efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive children aged 6 to 17 years.

Authors:  Howard Trachtman; James W Hainer; Jennifer Sugg; Renli Teng; Jonathan M Sorof; Jerilynn Radcliffe
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-10       Impact factor: 3.738
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.